Fw: NIH to Test Drug-Infused Vaginal Ring for HIV Prevention in Women

[Guest guest]

- NIH to Test Drug-Infused Vaginal Ring for HIV Prevention in Women

Sent: Jul 26, 2012 2:03 PM

Learn more about NIAID and how you can play a role in this exciting and dynamic

research organization:

Visit us on the Web Follow us on Twitter Visit us on Facebook Follow us on

LinkedIn NIH to Test Drug-Infused Vaginal Ring for HIV Prevention in Women

Researchers will launch a large, multinational clinical trial this month to test

the effectiveness and extended safety of a vaginal ring containing an

experimental antiretroviral drug to prevent HIV infection in women. With a

projected 3,476 participants, the MTN 020 study, otherwise known as, “A Study to

Prevent Infection with a Ring for Extended Use (ASPIRE),” aims to determine

whether the drug dapivirine can safely prevent HIV infection when continuously

released in the vagina from a silicone ring replaced once a month.

Learn more about the ASPIRE study.

Update your subscriptions, modify your password or e-mail address, or stop

subscriptions at any time on your Subscriber Preferences Page. You will need to

use your e-mail address to log in. If you have questions or problems with the

subscription service, please contact support@....

This service is provided to you at no charge by National Institute of Allergy

and Infectious Diseases (NIAID).

This email was sent to powertx@... using GovDelivery, on behalf of: National

Institute of Allergy and Infectious Diseases · 6610 Rockledge Drive · Bethesda,

MD 20892 · 866-284-4107